Anti-thrombotic and anti-inflammatory activity of sulodexide compared to aspirin in the rat model

Clin Hemorheol Microcirc. 2021;77(4):435-442. doi: 10.3233/CH-201043.

Abstract

Background: Although the number of vascular surgeries performed is increasing, the incidence of complications associated with this surgery has not improved and re-operations are frequently required. Thrombosis in a vessel is the most hazardous postoperative complication.

Objective: The aim of this study was to evaluate the anti-thrombotic and anti-inflammatory effects of sulodexide compared to aspirin in a rat model.

Methods: We divided the animals into three groups (sham (saline), aspirin, and sulodexide). The abdominal aorta was surgically opened and closed, primarily with 8/0 Prolene sutures. Postoperatively, saline, aspirin, or sulodexide was administered by oral gavage for 14 days to the rats. The degree of neovascularization, thrombus, calcification, inflammatory infiltrates, and fibrosis were analyzed histopathologically by hematoxylin and eosin staining.

Results: There was no significant difference in the incidence of postoperative thrombogenesis, but less calcification and inflammatory infiltrates were observed in the sulodexide group compared to the aspirin group. Histopathologic score revealed less infiltration of inflammatory cells and mild calcification for the sulodexide group (0.17±0.41 and 1.33±0.52, respectively) compared to the aspirin group (0.67±0.52 and 1.67±0.52, respectively) at days 14.

Conclusions: This study offers the possibility that sulodexide could be used as an aspirin substitute for the postoperative management of vascular patients, with low gastrointestinal discomfort. In addition, it may also offer reduced postoperative calcification and inflammation.

Keywords: Sulodexide; aspirin; calcification; inflammation; thrombogenesis.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use*
  • Anticoagulants / pharmacology
  • Anticoagulants / therapeutic use*
  • Aspirin / pharmacology
  • Aspirin / therapeutic use*
  • Disease Models, Animal
  • Glycosaminoglycans / pharmacology
  • Glycosaminoglycans / therapeutic use*
  • Humans
  • Inflammation / drug therapy*
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Thrombosis / drug therapy*

Substances

  • Anti-Inflammatory Agents
  • Anticoagulants
  • Glycosaminoglycans
  • glucuronyl glucosamine glycan sulfate
  • Aspirin